FDO Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
2017
Q3
$1.22M Sell
2017
Q2
$1.86M Buy
2017
Q1
$497K Buy